These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity. Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993 [TBL] [Abstract][Full Text] [Related]
6. Paediatric hypertension-associated erythromelalgia responds to corticosteroids and is not associated with SCN9A mutations. Morales PS; Escobar RG; Lizama M; Aglony M; Salomon J; Drenth JP; Borzutzky A Rheumatology (Oxford); 2012 Dec; 51(12):2295-6. PubMed ID: 22718865 [No Abstract] [Full Text] [Related]
7. Mining the Na Chew LA; Bellampalli SS; Dustrude ET; Khanna R Biochem Pharmacol; 2019 May; 163():9-20. PubMed ID: 30699328 [TBL] [Abstract][Full Text] [Related]
8. [Genetic variation may influence the development of persistent postsurgical pain]. Jeppesen MH; Gögenur I Ugeskr Laeger; 2014 Nov; 176(47):. PubMed ID: 25430537 [TBL] [Abstract][Full Text] [Related]
9. [Human pain channelopathies]. Rugiero F Med Sci (Paris); 2010 Dec; 26(12):1015-7. PubMed ID: 21187031 [No Abstract] [Full Text] [Related]
10. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics. Goldberg YP; Pimstone SN; Namdari R; Price N; Cohen C; Sherrington RP; Hayden MR Clin Genet; 2012 Oct; 82(4):367-73. PubMed ID: 22845492 [TBL] [Abstract][Full Text] [Related]
11. Primary erythromelalgia in a 12-year-old boy: positive response to sodium channel blockers despite negative SCN9A mutations. Jakob A; Creutzfeldt R; Staszewski O; Winterpacht A; Berner R; Hufnagel M Klin Padiatr; 2012 Sep; 224(5):309-12. PubMed ID: 22170168 [TBL] [Abstract][Full Text] [Related]
12. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H. Vasylyev DV; Han C; Zhao P; Dib-Hajj S; Waxman SG J Neurophysiol; 2014 Apr; 111(7):1429-43. PubMed ID: 24401712 [TBL] [Abstract][Full Text] [Related]
13. A new Nav1.7 mutation in an erythromelalgia patient. Estacion M; Yang Y; Dib-Hajj SD; Tyrrell L; Lin Z; Yang Y; Waxman SG Biochem Biophys Res Commun; 2013 Mar; 432(1):99-104. PubMed ID: 23376079 [TBL] [Abstract][Full Text] [Related]
14. Reduction in pain following treatment with ranolazine in primary erythromelalgia: a case report. Greco C; Chaumon S; Viallard ML; Bodemer C Br J Dermatol; 2018 Sep; 179(3):783-784. PubMed ID: 29624653 [No Abstract] [Full Text] [Related]
15. Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. Natkunarajah J; Atherton D; Elmslie F; Mansour S; Mortimer P Clin Exp Dermatol; 2009 Dec; 34(8):e640-2. PubMed ID: 19549232 [TBL] [Abstract][Full Text] [Related]
16. No gain, no pain: NaV1.7 as an analgesic target. King GF; Vetter I ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714 [TBL] [Abstract][Full Text] [Related]
17. Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile. McDonnell A; Schulman B; Ali Z; Dib-Hajj SD; Brock F; Cobain S; Mainka T; Vollert J; Tarabar S; Waxman SG Brain; 2016 Apr; 139(Pt 4):1052-65. PubMed ID: 26920677 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic divergence in the TRPA1 promoter correlates with pressure pain thresholds in healthy individuals. Gombert S; Rhein M; Eberhardt M; Münster T; Bleich S; Leffler A; Frieling H Pain; 2017 Apr; 158(4):698-704. PubMed ID: 28030472 [TBL] [Abstract][Full Text] [Related]